Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) Dividend History

Pharming Group N.V. ADS is a biopharmaceutical company specializing in the development of innovative therapies for rare, unmet medical needs. The company focuses on producing recombinant protein therapies, including treatments for genetically defined diseases and conditions involving enzyme deficiencies. Pharming is known for its flagship product, Rapyda, used in the treatment of hereditary angioedema. The company's operations are centered around developing and commercializing biologic medicines for patients worldwide.

Website: https://www.pharming.com

Dividend History

Pharming Group N.V. ADS, each representing 10 ordinary shares currently does not pay dividends

Company News

  • Pharming Group to participate in March investor conference

    Pharming Group N.V., a global biopharmaceutical company, announces that its management team will participate in the 37th Annual Roth Conference in March 2025, where they will hold a fireside chat and be available for one-on-one meetings.

    GlobeNewswire Inc.
  • Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

    Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

    Zacks Investment Research
    Featured Companies: URGN
  • IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday

    U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session. Impinj, Inc. (NASDAQ: PI) shares rose 31% to $65.06 after the company reported better-than-expected third-quarter revenue results. Bel Fuse Inc. (NASDAQ: BELFB) surged 23.4% to $48.61 after the company reported third-quarter financial results. Endeavor Group Holdings, Inc. (NYSE: EDR) gained 22.2% to $21.65 after the company announced a review of strategic alternatives. ImmunityBio, Inc. (NASDAQ: IBRX) rose 21.7% to $1.92. The FDA accepted ImmunityBio's resubmission of its Biologics License Application for N-803 as complete. First Foundation Inc. (NYSE: FFWM) shares climbed 13.9% to $5.57 following upbeat quarterly results. Blueprint Medicines Corporation (NASDAQ: BPMC) climbed 19.4% to $52.49 following strong quarterly results. Sunnova Energy International Inc. (NYSE: NOVA) rose 17.3% to $9.40 following third-quarter results. NETGEAR, Inc. (NASDAQ: NTGR) gained 15.5% to $12.05 after the company reported better-than-expected third-quarter financial results. Pharming Group N.V. (NASDAQ: PHAR) rose 13.8% to $11.38 after the company reported a year-over-year increase in third-quarter revenue results. Eagle Bancorp, Inc. (NASDAQ: EGBN) climbed 13% to $19.97 after the company reported ...

    Benzinga
    Featured Companies: AOS BELFB BPMC BPOP CFFN CFR CHE COLB EGBN EME FCN FFWM FIBK FLEX FTI HCSG HSII IBM IBRX ITGR LII MAS MBLY MORN MPW NOVA NOW NTGR PCT PI SAH TROX WTW
Page data last updated 07/23/2025 02:03:07 UTC